Monitoring bacteriostasis in allergen extract mixing: 10 years of culture data

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 5, 2009, Pages 1175-1176

  Letz, Adrian G ^a   Tankersley, Michael S ^a   Dice, John P ^a   England, Ronald W ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN;

ASEPSIS; BACTERIOSTASIS; BACTERIUM CULTURE; DRUG CONTAMINATION; DRUG FORMULARY; DRUG SAFETY; ENTEROCOCCUS; IMMUNOTHERAPY; LETTER; MONITORING; NONHUMAN; PRIORITY JOURNAL;

ALLERGENS; BACTERIA; CELLS, CULTURED; DESENSITIZATION, IMMUNOLOGIC; DRUG CONTAMINATION; HUMANS; HYPERSENSITIVITY; SAFETY;

EID: 67349091721     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.01.048     Document Type: Letter

References (7)

1. Joint Council of Allergy, Asthma and Immunology. News you can use: USP 797 update and recommendations. Available at: http://www.jcaai.org/page/122473/index.v3page?sc_v=r&sc_eid=50838 (JCAAI membership login required). Accessed December 3, 2008.
2. Noon L., and Cantab B.C. Prophylactic inoculation against hay fever. Lancet 1 (1911) 1572-1573
3. Cox L, Li JT, Nelson H, Lockey R, editors. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol 2007;120(suppl):S1-85.
4. Lay P.C., Bass R., and Lin S.Y. Allergen vial mixing and immunotherapy: risks of infections and vial contamination. Otolaryngol Head Neck Surg 137 (2007) 243-245
5. Correction for Table VIII. Allergen immunotherapy extract preparation guidelines. J Allergy Clin Immunol 122 (2008) 842
6. United States Pharmacopeia. USP <797> guidebook to pharmaceutical compounding-sterile preparations (2008), US Pharmacopeia, Rockville (MD)
7. Lay P.C., Bass R., Hughes L.F., and Lin S.Y. Risks of allergy vial contamination: comparison of mixing in-office versus under ventilation hood. Otolaryngol Head Neck Surg 139 (2008) 364-366